Ligand validation:7VB3

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7VB3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VB3_NAD_B_501	98%	58%	0.063	0.983	0.74	0.87	-	2	0	0	100%	1
7VB3_NAD_C_501	97%	57%	0.06	0.978	0.83	0.82	2	2	0	0	100%	1
7VB3_NAD_A_501	97%	54%	0.065	0.982	0.69	1.06	1	4	0	0	100%	1
7VB3_NAD_D_501	95%	55%	0.065	0.971	0.8	0.92	1	1	0	0	100%	1
7VB5_NAD_A_501	99%	57%	0.051	0.987	0.76	0.88	1	2	0	0	100%	1
7VB6_NAD_B_501	96%	59%	0.07	0.98	0.68	0.87	-	2	0	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.